INSPIREMD
InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard. The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD’s mission is to utilize its proprietary technology to make its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting: embolic showers, restenosis, and late stent thrombosis. InspireMD intends to pursue applications of its innovative technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures.
INSPIREMD
Industry:
Biopharma Biotechnology Health Care Medical Device
Founded:
2005-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.inspiremd.com
Total Employee:
51+
Status:
Active
Contact:
857-453-6553
Total Funding:
93.63 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Board_member
Board_member
Board_member
Advisor
Advisor
Advisor
Board_member
Advisor
Current Employees Featured
Chaim Lotan CMO @ InspireMD
CMO
David Blossom VP of Global Marketing & Strategy @ InspireMD
VP of Global Marketing & Strategy
Alan W. Millinazzo Chief Executive Officer, President and Director @ InspireMD
Chief Executive Officer, President and Director
Gwen Bame VP of Corporate Development @ InspireMD
VP of Corporate Development
Craig Shore CFO @ InspireMD
CFO
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - InspireMD
Official Site Inspections
http://www.inspiremd.com Semrush global rank: 5.17 M Semrush visits lastest month: 1.56 K
- Host name: cloudproxy10138.sucuri.net
- IP address: 192.124.249.138
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "InspireMD"
Company - InspireMD
InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) delivering neurovascular protection and stroke prevention. Proprietary …See details»
Investor Relations - InspireMD
InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) delivering neurovascular protection …See details»
InspireMD - LinkedIn
InspireMD | 5,072 followers on LinkedIn. Best-in-class results for life sustaining Carotid disease solutions using proprietary technology implant (CGuard Prime) | InspireMD is a commercial-stage ...See details»
InspireMD - Crunchbase Company Profile & Funding
InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard. The company intends to …See details»
InspireMD Announces Establishment of Global Headquarters in
Oct 15, 2024 InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and …See details»
InspireMD Inc Company Profile - Overview - GlobalData
InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid …See details»
InspireMD (NASDAQ:NSPR) – A Comprehensive Look at the …
Nov 30, 2024 InspireMD, Inc. is a pioneering medical device company that has firmly established itself as a formidable player in the carotid artery disease and stroke prevention …See details»
InspireMD Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has …See details»
InspireMD Announces Establishment of Global Headquarters in …
Oct 15, 2024 Marvin Slosman, Chief Executive Officer of InspireMD, stated, News. ... training and sales operations teams in South Florida to form the foundation of a world-class US …See details»
News - InspireMD
TOLEDO, OHIO and TEL AVIV, ISRAEL – BUSINESSWIRE—SEPTEMBER 8, 2022—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc. …See details»
InspireMD announces CFO retirement, transition
Dec 12, 2024 InspireMD announced today that Craig Shore, the company's CFO, decided to retire after the company identifies and appoints a successor. ... “On behalf of the entire …See details»
InspireMD Announces Senior Leadership Changes to Support
Oct 3, 2023 In connection with the appointment of Dr. Patrick Verta as Executive Vice President of Clinical and Medical Affairs, InspireMD has granted Dr. Verta 139,740 shares of restricted …See details»
InspireMD Inc (NSPR) Q1 2025 Earnings Call Highlights: Revenue …
1 day ago InspireMD Inc (NASDAQ:NSPR) reported a 1.2% year-over-year growth in revenue, reaching $1.53 million for the first quarter of 2025. The company has sold approximately …See details»
InspireMD - Funding, Financials, Valuation & Investors - Crunchbase
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard. New. Resources. ... How much funding has this …See details»
InspireMD Announces Inducement Grants Under Nasdaq
MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the …See details»
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
3 days ago InspireMD, Inc. (NSPR) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.21 per share a year …See details»
Corporate Governance - InspireMD
Info@inspiremd.com 1-888-425-3292. USA Headquarters 6303 Waterford District Dr Suite 215 Miami, FL 33126. Israel Menorat Hamaor 4 Tel Aviv 6744832 Tel: +972 3 6917691 Email: …See details»
InspireMD - YouTube
Share your videos with friends, family, and the worldSee details»
InspireMD, Inc. (NASDAQ:NSPR) Q1 2025 Earnings Call Transcript
1 day ago InspireMD, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.17. Operator: Good morning, and welcome to InspireMD’s First Quarter …See details»
Contact Us - InspireMD
Info@inspiremd.com 1-888-425-3292. USA Headquarters 6303 Waterford District Dr Suite 215 Miami, FL 33126. Israel Menorat Hamaor 4 Tel Aviv 6744832 Tel: +972 3 6917691 Email: …See details»